Tackle the biggest, most iconic marathon in the UK for Leuka, and help leukaemia and blood cancer patients live healthier and more fulfilled lives.
If you're wondering how to get a place in the London Marathon for 2019, look no further. You could be running 26.2 miles through the closed roads of London, passing some of the greatest landmarks the city has to offer, and finishing strong on Pall Mall. People will be lining the streets of London, cheering you on, and you'll cross the finish line feeling like a superstar. What an achievement! There’s really no running experience like it.
Plus, if you run the London Marathon for a specialist cancer charity like ours, you'll be making a real difference for leukaemia patients of the future.
Date: Sunday 28 April 2019
Registration fee: £75
Minimum sponsorship: £2000
We have ONE final charity place available for the London Marathon 2019! So, if you missed out in the public ballot, please do get in touch below.
The ballot for a place in the Virgin Money London Marathon 2019 has now closed - results were announced in mid October 2018.
If you gained a ballot place, you can join #TeamLeuka for the 2019 London Marathon with no minimum fundraising pledge! You will simply be asked to raise as much as you can, before you tackle the run on the big day.
If you were lucky enough to gain a ballot place, please do email Simona at firstname.lastname@example.org to join the team and get your fundraising pack!
What you get with #TeamLeuka:
- Personal support from our friendly fundraising team!
- A helpful fundraising kit
- A technical running vest
Why support us:
We are a small, specialist cancer charity who fund leukaemia and blood cancer research. Every day 27 people are diagnosed with leukaemia: that’s more than one every hour. Our vital work aims to translate research findings into new leukaemia treatments as quickly as possible, so patients can live better, longer lives. Research like the IMPACT stem cell clinical trials network, which aims to improve stem cell transplant treatments and get more patients into life-saving clinical trials.